Congratulations to Dr. Beth Sherry, the 14th graduate of our preventive cardiology fellowship program. Best wishes to Dr. Sherry as she embarks on a career in a large private practice where she will care for patients with lipid disorders and increased cardiovascular risk.

We are excited to welcome our new preventive cardiology fellow, Dr. Kalyani Dhar! Dr. Dhar received a medical degree at Rutgers Robert Wood Johnson Medical School and completed internal medicine residency at Stony Brook University and a Women’s Health Fellowship at Northwell.

#1 in New York and #2 in the Nation according to U.S. News & World Report! So proud of our faculty, fellows and staff NYU Langone Health who strive each and every day to provide world-class cardiovascular care.

U.S. News & World Report released their latest rankings of hospitals for 2024-2025 and we are excited to share that NYU Langone Health is home to the most top 10-ranked specialties in New York. Learn more about the rankings: nyulangone.org/news/nyu-lango…

Our preventive cardiologist, Dr. Sean Heffron, advises patients to explore a variety of vegetables beyond the usual year-round options like broccoli and onions. Discover the benefits of seasonally eating. ⤵️ apnews.com/article/eating…

Check out this simple strategy for improving your heart and overall heath long-term that our Founding Director Dr. Edward Fisher swears by🚶🏼‍♂️💜 parade.com/health/simple-…

Diet and lifestyle are key to reducing risk for #cardiovascular disease and related comorbidities. Join us to hear from over a dozen experts on ways to approach diet and lifestyle recommendations for patients, jointly sponsored NYACP. Learn more ⤵️bit.ly/4bTirOG

NYACP is proud to Sponsor NYU CVD Prevention ! Learn more about the event and topics: highmarksce.com/nyumc/index.cf…

Our #CardioRheum expert, Dr. Michael Garshick, is a featured guest speaker at this upcoming hybrid conference exploring #atherosclerosis and #inflammation. Learn more: bit.ly/3AeQXWB theheartorg | Medscape theheartorg-Medscape Dr. Michael Garshick MedscapeLIVE

NYU CVD Prevention Brittany Weber

Reunited! Dr. Michael Garshick, Dr. Brittany Weber and Dr. Paul Ridker together again for a Medscape session being held tomorrow covering #ASCVD #CKD and #inflammation. Join them virtually: bit.ly/3LP7HGz

40K in the U.S. experience #recurrentpericarditis, or inflammation of the structure protecting the heart. We are one of 15 participating sites in a new American Heart Association effort to better inform care decisions. Learn more 👉 hrt.mobi/RecurrentPeric…

Out now!!🔥Our comprehensive review of HFpEF 🫀in Nature Reviews Disease Primers. A labor of love and a privilege to work with HFpEF giants Carolyn Lam Sanjiv J. Shah, MD Scott Solomon Lars Lund rdcu.be/dQTk7

Att: Clinicians! Don’t miss this CME, offering valuable and practical guidance on lifestyle modifications for #cardiovascular risk reduction, including exercise, diet, and #integrativemedicine strategies. Jointly sponsored by NYACP: bit.ly/4bTirOG #CardioTwitter

Finally! A circulating platelet genetic signature (PRESS)🔥that predicts platelet hyperreactivity and increased cardiovascular risk. Collaborative science is awesome!! Tessa Barrett 👩‍🔬🧫🫀🧬🗽🇦🇺 Nathaniel Smilowitz NYU CVD Prevention NYU CVRC nature.com/articles/s4146…

Our Platelet Reactivity ExpreSsion Score (PRESS) paper is online! PRESS opens the possibility of a precision medicine approach to CVD risk reduction🧬 🫀🩸 A large effort spanning basic, clinical & bioinformatic science to develop a blood signature of platelet reactivity.

"Using PRESS, we will be able to identify people who have platelet hyperreactivity ... who would most likely have the greatest benefit from an antiplatelet therapy drug," Nature Communications Dr. Jeffrey Berger NYU Langone Health Healio #Cardiotwitter Read more👇 healio.com/news/cardiolog…

Our experts and colleagues report on #cardiovascular adverse event reporting in #psoriasis and #psoriaticarthritis biological therapy clinical trials in WDS. Learn more: bit.ly/4dAidOm

Clinicians! Join us for this innovative CME course to learn how to effectively prescribe new weight-loss therapies to treat #obesity & lower #CVD risk and how to counsel patients on nutritional considerations when taking #GLP1 medications. NYC + Online: bit.ly/4bTirOG

Research News! “PRESS promises to help physicians confine anti-platelet treatment to the people most likely to benefit: those with platelet hyperreactivity," said corresponding study author Jeffrey Berger, MD. Dr. Jeffrey Berger Tessa Barrett 👩‍🔬🧫🫀🧬🗽🇦🇺 Nathaniel Smilowitz NYU CVRC NYU Grossman School of Medicine